Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model

P Sandbhor, J Goda, B Mohanty, P Gera… - Drug Delivery and …, 2023 - Springer
Nanotechnology-based drug delivery platforms have shown great potential in overcoming
the limitations of conventional therapy for glioblastoma (GBM). However, permeation across …
被引用次数：13 相关文章
[PDF] researchgate.net

[PDF][PDF] Targeted nano‑delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model

P Sandbhor, J Goda, B Mohanty, P Gera, S Yadav… - 2022 - researchgate.net
Nanotechnology-based drug delivery platforms have shown great potential in overcoming
the limitations of conventional therapy for glioblastoma (GBM). However, permeation across …

Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model.

P Sandbhor, J Goda, B Mohanty, P Gera… - Drug Delivery and …, 2022 - europepmc.org
Nanotechnology-based drug delivery platforms have shown great potential in overcoming
the limitations of conventional therapy for glioblastoma (GBM). However, permeation across …

Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model

P Sandbhor, J Goda, B Mohanty… - Drug delivery and …, 2023 - pubmed.ncbi.nlm.nih.gov
Nanotechnology-based drug delivery platforms have shown great potential in overcoming
the limitations of conventional therapy for glioblastoma (GBM). However, permeation across …